I’ll lay out how the country suddenly woke to the harms of cannabis, why that matters, how the media and industry reacted, the weight of personal stories, and what this shift could mean for policy and families. The piece argues from a conservative perspective that we need to confront the psychiatric and cultural consequences of high-potency THC and the commercialization that pushed it. It points to new research, a book about violence in the marijuana trade, and viral testimony that cut through the noise. The tone is direct: this is a public-health problem that too many people still treat like a stunt or a social panacea.
In recent weeks a flurry of attention landed on cannabis and its dangers, especially for young people. Canadian researchers reported alarming spikes in severe mental illness where high-potency cannabis is common, and that study has people finally paying attention. The timing felt sudden, but the risks have been accumulating with each new, stronger product that hits the market.
At the same time a new book, “A Killing In Cannabis”, reminded readers that violence is woven into the weed business and that legalization did not magically erase those problems. Illegal markets, organized crime, and brutal disputes did not disappear just because states changed laws. That reality complicates the naïve idea that legalization was a tidy fix for every social ill tied to prohibition.
Even a once-center-left editorial institution has started to admit the country faces a “Marijuana Problem”, acknowledging addiction and psychosis are real concerns. Calls to ban THC extracts surfaced as one solution, a proposal that would, in effect, recriminalize parts of the legal industry. Those concentrated, near-pure THC products are the biggest profit center for the industry and the biggest risk for heavy users.
THC is the ingredient that produces the high, and vaping technology delivers potent, near-pure hits that were never part of the old recreational picture. The commercialization of these products pushed potency ever higher and normalized regular use among teens and young adults. That pattern has predictable public-health consequences, and we are watching those consequences show up in psychiatric wards and on city streets.
I warned about this in “Tell Your Children”, a book that collected decades of research linking cannabis and THC exposure to mental illness, particularly psychosis and schizophrenia. The industry and many allies fought hard to dismiss those findings, treating caution as if it were a political attack instead of a medical warning. That dynamic has made honest debate difficult for years.
Legacy media outlets and influential platforms too often helped the industry narrative by refusing to give skeptical voices fair hearings. Reports and interviews were canceled, reviews delayed, and criticism labeled as polemic instead of treated as a scientific discussion. That behavior is part of a larger refusal among elites to confront uncomfortable trade-offs of legalization when they had already decided the moral case.
As I argued in “Pandemia”, the groupthink around cannabis turned complex questions into a single moral slogan: legalization equals justice. Once that frame dominated, any dissent was dismissed as bad faith. That intellectual shortcut insulated the industry from scrutiny and made it harder for parents and clinicians to get clear information on risk.
What finally seems to be breaking the spell is not another editorial but lived experience. Families are seeing young people implode or spiral into psychosis after heavy THC use, and those stories land harder than any policy paper. A conservative commentator shared a wrenching account on social media about a sibling whose life was wrecked by cannabis-related schizophrenia, and that testimony reached millions.
First-person accounts have an emotional power research papers rarely match, because “People like to read about people.” Hearing from a friend, sibling, or neighbor makes the data personal and urgent. Those testimonies are shrinking the distance between abstract risk and daily reality, and they are changing how many Americans think about legalization and safety.
President Trump’s decision in December to “reschedule” cannabis worried many conservatives who see rescheduling as a regulatory misstep that could normalize heavier use. The fight over cannabis is cultural and medical, not merely legal, and straightforward policy shifts without cultural reckoning will not fix the harms. A majority of Americans support full legalization, but most do not use cannabis and underestimate its danger for certain vulnerable groups.
The industry has spent decades and billions painting cannabis as harmless or therapeutic for nearly everything, and that messaging still has power. But when parents start looking for answers because their teenagers are hurting, old PR lines lose their grip. Right now a conservative push for honest public health messaging, stronger limits on high-potency products, and clearer warnings for young people feels like the common-sense next step.
Book sales for “Tell Your Children” have ticked up as readers search for explanations, and that market signal suggests the conversation is shifting. The immediate wave of attention will ebb, but personal testimony and mounting clinical evidence have already altered the debate in ways a few editorials never could. Tell Your Children.
